Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma JC Castle, M Loewer, S Boegel, J de Graaf, C Bender, AD Tadmor, ... BMC genomics 15, 1-12, 2014 | 379 | 2014 |
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors K Reinhard, B Rengstl, P Oehm, K Michel, A Billmeier, N Hayduk, O Klein, ... Science 367 (6476), 446-453, 2020 | 331 | 2020 |
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis C Krienke, L Kolb, E Diken, M Streuber, S Kirchhoff, T Bukur, ... Science 371 (6525), 145-153, 2021 | 301 | 2021 |
HLA typing from RNA-Seq sequence reads S Boegel, M Löwer, M Schäfer, T Bukur, J De Graaf, V Boisguérin, ... Genome medicine 4, 1-12, 2013 | 291 | 2013 |
Multi-omics characterization of the 4T1 murine mammary gland tumor model B Schrörs, S Boegel, C Albrecht, T Bukur, V Bukur, C Holtsträter, C Ritzel, ... Frontiers in oncology 10, 1195, 2020 | 141 | 2020 |
HLA and proteasome expression body map S Boegel, M Löwer, T Bukur, P Sorn, JC Castle, U Sahin BMC medical genomics 11, 1-12, 2018 | 115 | 2018 |
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines S Boegel, M Löwer, T Bukur, U Sahin, JC Castle Oncoimmunology 3 (8), e954893, 2014 | 111 | 2014 |
HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory C Grunwitz, N Salomon, F Vascotto, A Selmi, T Bukur, M Diken, S Kreiter, ... Oncoimmunology 8 (9), e1629259, 2019 | 68 | 2019 |
TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression J Scholtalbers, S Boegel, T Bukur, M Byl, S Goerges, P Sorn, M Loewer, ... Genome medicine 7, 1-7, 2015 | 68 | 2015 |
Cell contact–dependent priming and Fc interaction with CD32+ immune cells contribute to the TGN1412-triggered cytokine response P Bartholomaeus, LY Semmler, T Bukur, V Boisguerin, PS Roemer, ... The Journal of Immunology 192 (5), 2091-2098, 2014 | 64 | 2014 |
Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates B Schrörs, P Riesgo-Ferreiro, P Sorn, R Gudimella, T Bukur, T Rösler, ... PLoS One 16 (9), e0249254, 2021 | 37 | 2021 |
A liposomal RNA vaccine inducing neoantigen-specific CD4+ T cells augments the antitumor activity of local radiotherapy in mice N Salomon, F Vascotto, A Selmi, M Vormehr, J Quinkhardt, T Bukur, ... Oncoimmunology 9 (1), 1771925, 2020 | 37 | 2020 |
Bioinformatics for cancer immunotherapy C Holtsträter, B Schrörs, T Bukur, M Löwer Bioinformatics for Cancer Immunotherapy: Methods and Protocols, 1-9, 2020 | 32 | 2020 |
Traveling salesman problem with clustering JJ Schneider, T Bukur, A Krause Journal of Statistical Physics 141, 767-784, 2010 | 14 | 2010 |
Tumor antigens for determining cancer therapy U Sahin, C Paret, K Vormbrock, C Bender, P Simon, C Hartmann, ... US Patent 10,188,712, 2019 | 10 | 2019 |
HLA typing from RNA-seq sequence reads. Genome Med 4: 102 S Boegel, M Löwer, M Schäfer, T Bukur, J de Graaf, V Boisguerin, ... | 9 | 2012 |
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines. Oncoimmunology 3: e954893 S Boegel, M Lower, T Bukur, U Sahin, JC Castle | 8 | 2014 |
In silico typing of classical and non-classical HLA alleles from standard RNA-Seq reads S Boegel, T Bukur, JC Castle, U Sahin HLA Typing: Methods and Protocols, 177-191, 2018 | 7 | 2018 |
Positive role of the MHC class-I antigen presentation regulator m04/gp34 of murine cytomegalovirus in antiviral protection by CD8 T cells S Becker, A Fink, J Podlech, I Giese, JK Schmiedeke, T Bukur, ... Frontiers in Cellular and Infection Microbiology 10, 454, 2020 | 6 | 2020 |
CoVigator—A Knowledge Base for Navigating SARS-CoV-2 Genomic Variants T Bukur, P Riesgo-Ferreiro, P Sorn, R Gudimella, J Hausmann, T Rösler, ... Viruses 15 (6), 1391, 2023 | 4 | 2023 |